GOLT1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.543800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.675600E-01
Normal-vs-Stage2
8.727200E-01
Normal-vs-Stage3
7.550400E-01
Normal-vs-Stage4
4.126600E-01
Stage1-vs-Stage2
6.878200E-01
Stage1-vs-Stage3
8.397800E-01
Stage1-vs-Stage4
3.945400E-01
Stage2-vs-Stage3
5.970400E-01
Stage2-vs-Stage4
4.417200E-01
Stage3-vs-Stage4
3.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.603400E-01
Normal-vs-AfricanAmerican
7.265600E-01
Normal-vs-Asian
9.013400E-01
Caucasian-vs-AfricanAmerican
8.279000E-01
Caucasian-vs-Asian
5.844200E-01
AfricanAmerican-vs-Asian
5.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.329400E-01
Normal-vs-Female
7.343200E-01
Male-vs-Female
3.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.532000E-01
Normal-vs-Age(41-60Yrs)
4.591400E-01
Normal-vs-Age(61-80Yrs)
9.425000E-01
Normal-vs-Age(81-100Yrs)
8.197800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.849070E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.161640E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.040200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.140400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.174100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.789600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.461000E-01
Normal-vs-Daily Drinker
7.951800E-01
Normal-vs-Weekly Drinker
8.702200E-01
Normal-vs-Occasional Drinker
6.220600E-01
Normal-vs-Social Drinker
5.403000E-01
Non Drinker-vs-Daily Drinker
9.393800E-01
Non Drinker-vs-Weekly Drinker
2.736800E-01
Non Drinker-vs-Occasional Drinker
7.790400E-02
Non Drinker-vs-Social Drinker
5.003600E-02
Daily Drinker-vs-Weekly Drinker
4.677600E-01
Daily Drinker-vs-Occasional Drinker
1.622050E-01
Daily Drinker-vs-Social Drinker
1.530570E-01
Weekly Drinker-vs-Occasional Drinker
4.877200E-01
Weekly Drinker-vs-Social Drinker
4.439200E-01
Occasional Drinker-vs-Social Drinker
9.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.711200E-01
Normal-vs-Grade 2
7.769000E-01
Normal-vs-Grade 3
4.593000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.270600E-01
Grade 1-vs-Grade 3
3.713800E-01
Grade 1-vs-Grade 4
5.711200E-01
Grade 2-vs-Grade 3
3.124800E-01
Grade 2-vs-Grade 4
7.769000E-01
Grade 3-vs-Grade 4
4.593000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.043800E-01
Normal-vs-NonDiabetic
8.564800E-01
Diabetic-vs-NonDiabetic
7.874100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.073400E-01
Normal-vs-NoPancreatitis
8.926000E-01
Pancreatitis-vs-NoPancreatitis
1.650780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.566000E-01
Normal-vs-N1
8.615400E-01
N0-vs-N1
9.185000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.374780E-01
Normal-vs-TP53-NonMutant
9.634400E-01
TP53-Mutant-vs-TP53-NonMutant
5.453800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
